Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney

Pharmaceutical Research

Volumn 14, Issue 10, 1997, Pages 1466-1471

  Strong, Michelle L ^a,b   Ueda, Clarence T ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cyclosporine A; Cyclosporine G; High density lipoprotein; Isolated perfused kidney; Low density lipoprotein; Renal clearance

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN G; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; IN VITRO STUDY; KIDNEY CLEARANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BLOOD PROTEINS; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0030727770     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012141309951     Document Type: Article

References (30)

1. B. D. Kahan. New Engl. J. Med. 321:1725-1738 (1989).
2. G. C. Yee and D. R. Salomon. W. E. Evans, J. J. Schentag, W. J. Jusko (eds.) Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, 3rd ed Applied Therapeutics, Inc., Vancouver, WA, 1992, Chapt. 28, pp. 28-1-28-40.
3. J. R. Jeffrey. Clin. Biochem. 24:15-21 (1991).
4. M. Lemaire and J. P. Tillement. J. Pharm. Pharmacol. 34:715-718 (1982).
5. W. Niederberger, M. Lemaire, G. Maurer, K. Nussbaumer, and O. Wagner. Transplant. Proc. 15:2419-2421 (1983).
6. D. Sgoutas, W. MacMahon, A. Love, and I. Jerkunica. J. Pharm. Pharmacol. 38:583-588 (1986).
7. B. Legg and M. Rowland. J. Pharm. Pharmacol. 39:599-603 (1987).
8. S. Urien, R. Zini, M. Lemaire, and J. P. Tillement. J. Pharmacol. Exp. Ther. 253:305-309 (1990).
9. W. M. Awni, B. L. Kasiske, K. Heim-Duthoy, and K. V. Rao. Clin. Pharmacol. Ther. 45:41-48 (1989).
10. F. Kronenberg, H. Dieplinger, P. Konig, and G. Utermann. Isr. J. Med. Sci. 32:371-389 (1996).
11. M. S. Markell and E. A. Friedman. Am. J. Med. 87:5-61N-5-67N (1989).
12. J. M. Nishiitsutsuji-Uwo, B. D. Ross, and H. A. Krebs. Biochem. J. 103:852-862 (1967).
13. T. Maack. Kidney Int. 30:142-151 (1986).
14. F. H. Epstein, J. T. Brosnan, and J. D. Tange. Am. Physiol. Soc. pp. F284-F292 (1982).
15. H. A. Krebs and K. Henseleit. Z. Physiol. Chem. 210:33-66 (1932).
16. A. C. Guyton. Textbook of Medical Physiology, W.B. Saunders Company, Philadelphia, PA, 1976, Chapt. 68, pp. 916-927.
17. M. Burstein, H. R. Scholnic, and R. Morfin. J. Lipid Res. 11:583-594 (1970).
18. Beckman Paragon Electrophoresis System Instructions. Lipoprotein Electrophoresis, Brea, CA, Beckman Instruments, 1981.
19. I. Bekersky. Drug Metab. Rev. 14:931-960 (1983).
20. P. Trinder. Ann. Clin. Biochem. 6:24 (1969).
21. R. H. Bowman and T. Maack. Am. J. Physiol. 222:1499-1504 (1972).
22. A. Besarab, P. Silva, B. D. Ross, and F. H. Epstein. Am. J. Physiol. 228:1525-1530 (1975).
23. M. Bradford. Anal. Biochem. 72:248-254 (1976).
24. T. P. Moyer, P. Johnson, S. M. Faynor, and S. Sterioff. Clin. Biochem. 19:83-89 (1986).
25. A. C. Guyton. Textbook of Medical Physiology, W.B. Saunders Company, Philadelphia, PA, 1976, Chapt. 34, pp. 438-455.
26. N. Rifai, F-F Chao, Q. Pham, J. Thiessen, and S. J. Soldin. Clin. Biochem. 29:149-155 (1996).
27. P. C. deGroen. Mayo Clin. Proc. 63:1012-1021 (1988).
28. P. C. deGroen, R. H. Wiesner, and R. A. F. Krom. Transplant. Proc. 20:374-376 (1988).
29. J. Lopez-Miranda, F. Perez-Jimenez, J. Blanco-Cerrada, A. Blanco-Molina, J. Torre-Cisneros, J. A. Jimenez-Pereperez. Transplante 1:100-103 (1990).
30. D. R. Luke, L. J. Brunner, G. Lopez-Berestein, and J. C. Yau. J. Pharm. Sci. 81:208-211 (1992).